About Cerus Endovascular
Cerus Endovascular is a company based in Oxford (United Kingdom) founded in 2011 was acquired by Stryker in May 2023.. Cerus Endovascular has raised $8.21 million across 2 funding rounds from investors including Stryker, Mid Atlantic Bio Angels and The North West Fund. The company has 14 employees as of December 31, 2021. Cerus Endovascular has completed 1 acquisition, including Stryker. Cerus Endovascular offers products and services including Bed Frames, Surgical Tools, and Emergency Patient Transport. Cerus Endovascular operates in a competitive market with competitors including Rapid Medical, Fluid Biomed, Oxford Endovascular, Anaconda Biomed and MicroVention, among others.
- Headquarter Oxford, United Kingdom
- Employees 14 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cerus Endovascular Limited
- Date of Incorporation 08 Dec, 2011
- Jurisdiction OXFORD, UNITED KINGDOM
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cerus Endovascular
Cerus Endovascular offers a comprehensive portfolio of products and services, including Bed Frames, Surgical Tools, and Emergency Patient Transport. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Hospital bed structures for patient care.
Devices for orthopaedic and neuro procedures.
Equipment for safe patient movement.
Unlock access to complete
Funding Insights of Cerus Endovascular
Cerus Endovascular has successfully raised a total of $8.21M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.91 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.9M
-
First Round
First Round
(06 Jun 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2019 | Amount | Series A - Cerus Endovascular | Valuation |
investors |
|
| Jun, 2013 | Amount | Seed - Cerus Endovascular | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cerus Endovascular
Cerus Endovascular has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, Mid Atlantic Bio Angels and The North West Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An angel investor group focused on life science companies.
|
Founded Year | Domain | Location | |
|
Venture debt firm
|
Founded Year | Domain | Location | |
|
3D-printed orthopedic products are manufactured for medical applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cerus Endovascular
Cerus Endovascular has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Stryker. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
3D-printed orthopedic products are manufactured for medical applications.
|
1941 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cerus Endovascular
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cerus Endovascular Comparisons
Competitors of Cerus Endovascular
Cerus Endovascular operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Medical, Fluid Biomed, Oxford Endovascular, Anaconda Biomed and MicroVention, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurovascular interventional devices including distal access catheters are developed.
|
|
| domain | founded_year | HQ Location |
A hybrid polymer-metal stent for brain aneurysms is developed.
|
|
| domain | founded_year | HQ Location |
Metallic mesh devices for brain aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for mechanical thromboectomy and clot removal are developed.
|
|
| domain | founded_year | HQ Location |
Neuroendovascular technologies for cerebral and peripheral vascular diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cerus Endovascular
Frequently Asked Questions about Cerus Endovascular
When was Cerus Endovascular founded?
Cerus Endovascular was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is Cerus Endovascular located?
Cerus Endovascular is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Cerus Endovascular a funded company?
Cerus Endovascular is a funded company, having raised a total of $8.21M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.3M, raised on Jun 06, 2013.
How many employees does Cerus Endovascular have?
As of Dec 31, 2021, the latest employee count at Cerus Endovascular is 14.
What does Cerus Endovascular do?
Cerus Endovascular was founded in 2011 and is based in Oxford, United Kingdom. The company focuses on the design and development of proprietary interventional neuroradiology devices and delivery systems. These are intended for use in minimally invasive procedures addressing neurovascular conditions, including intracranial aneurysms. Operations center on advancing treatments within the medical device sector for neurovascular applications.
Who are the top competitors of Cerus Endovascular?
Cerus Endovascular's top competitors include Rapid Medical, Fluid Biomed and Anaconda Biomed.
What products or services does Cerus Endovascular offer?
Cerus Endovascular offers Bed Frames, Surgical Tools, and Emergency Patient Transport.
How many acquisitions has Cerus Endovascular made?
Cerus Endovascular has made 1 acquisition, including Stryker.
Who are Cerus Endovascular's investors?
Cerus Endovascular has 3 investors. Key investors include Stryker, Mid Atlantic Bio Angels, and The North West Fund.